TURP for BPH better than watchful waiting in men with moderate symptoms -- study.
This article was originally published in The Gray Sheet
Executive Summary
TURP FOR BPH WITH MODERATE SYMPTOMS IS PREFERABLE TO "WATCHFUL WAITING," John Wasson, MD, et al. conclude in a study published Jan. 11 in the New England Journal of Medicine on the effectiveness of transurethral resection of the prostate in treating benign prostatic hyperplasia. "Men with moderate symptoms of [BPH] that substantially reduce the quality of their lives have the most to gain from transurethral resection," Wasson et al. conclude. "For men who are less bothered by urinary difficulties or who wish to delay surgery, watchful waiting is usually a safe alternative."
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.